166 related articles for article (PubMed ID: 11680266)
1. [The sympathetic nervous system activity estimated on serum concentration of chromogranin A in patients with the chronic heart failure].
Rubinsztajn R
Pol Arch Med Wewn; 2001 Mar; 105(3):217-24. PubMed ID: 11680266
[TBL] [Abstract][Full Text] [Related]
2. Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality.
Ceconi C; Ferrari R; Bachetti T; Opasich C; Volterrani M; Colombo B; Parrinello G; Corti A
Eur Heart J; 2002 Jun; 23(12):967-74. PubMed ID: 12069452
[TBL] [Abstract][Full Text] [Related]
3. [Changes in serum chromogranin A and urotensin II levels in children with chronic heart failure].
Cheng YY; An JD; Feng S; Ge W
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Mar; 19(3):313-317. PubMed ID: 28302203
[TBL] [Abstract][Full Text] [Related]
4. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
[TBL] [Abstract][Full Text] [Related]
5. Chromogranin A as serum marker of pituitary adenomas.
Gussi IL; Young J; Baudin E; Bidart JM; Chanson P
Clin Endocrinol (Oxf); 2003 Nov; 59(5):644-8. PubMed ID: 14616890
[TBL] [Abstract][Full Text] [Related]
6. Development of an ELISA for the detection of serum chromogranin A (CgA) in prostate and non-neuroendocrine carcinomas.
Tsao KC; Wu JT
Clin Chim Acta; 2001 Nov; 313(1-2):21-9. PubMed ID: 11694235
[TBL] [Abstract][Full Text] [Related]
7. Chromogranin A correlates with norepinephrine release rate.
Dimsdale JE; O'Connor DT; Ziegler M; Mills P
Life Sci; 1992; 51(7):519-25. PubMed ID: 1640800
[TBL] [Abstract][Full Text] [Related]
8. Comparison of chromogranin A (CgA) levels in serum and plasma (EDTA2K) and the respective reference ranges in healthy males.
Glinicki P; Jeske W; Kapuścińska R; Zgliczyński W
Endokrynol Pol; 2015; 66(1):53-6. PubMed ID: 25754282
[TBL] [Abstract][Full Text] [Related]
9. Response of sympathetic nervous system activity to exercise in patients with congestive heart failure.
Kinugawa T; Ogino K; Kitamura H; Miyakoda H; Saitoh M; Hasegawa J; Kotake H; Mashiba H
Eur J Clin Invest; 1991 Oct; 21(5):542-7. PubMed ID: 1752293
[TBL] [Abstract][Full Text] [Related]
10. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
[TBL] [Abstract][Full Text] [Related]
11. [Sympathetic nervous system response to exercise in patients with congestive heart failure].
Kinugawa T; Ogino K; Miyakoda H; Hasegawa J; Kotake H; Mashiba H
J Cardiol; 1989 Dec; 19(4):1127-35. PubMed ID: 2486631
[TBL] [Abstract][Full Text] [Related]
12. Effect of exercise training on chromogranin A and relationship to N-ANP and inflammatory cytokines in patients with chronic heart failure.
Larsen AI; Helle KB; Christensen M; Kvaløy JT; Aarsland T; Dickstein K
Int J Cardiol; 2008 Jun; 127(1):117-20. PubMed ID: 17586073
[TBL] [Abstract][Full Text] [Related]
13. Chromogranin A as tumor marker in medullary thyroid carcinoma.
Blind E; Schmidt-Gayk H; Sinn HP; O'Connor DT; Raue F
Thyroid; 1992; 2(1):5-10. PubMed ID: 1356053
[TBL] [Abstract][Full Text] [Related]
14. Development of a microplate assay for serum chromogranin A (CgA): establishment of normal reference values and detection of elevated CgA in malignant diseases.
Wu TL; Chang CP; Tsao KC; Sun CF; Wu JT
J Clin Lab Anal; 1999; 13(6):312-9. PubMed ID: 10633301
[TBL] [Abstract][Full Text] [Related]
15. The differences in chromogranin A (CgA) concentrations measured in serum and in plasma by IRMA and ELISA methods.
Glinicki P; Kapuścińska R; Jeske W
Endokrynol Pol; 2010; 61(4):346-50. PubMed ID: 20806177
[TBL] [Abstract][Full Text] [Related]
16. Serum chromogranin A in the diagnosis and follow-up of neuroendocrine tumors of the gastroenteropancreatic tract.
Schürmann G; Raeth U; Wiedenmann B; Buhr H; Herfarth C
World J Surg; 1992; 16(4):697-701; discussion 701-2. PubMed ID: 1413839
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of hyaluronic acid, procollagen type III NH2-terminal peptide, and laminin in patients with chronic congestive heart failure.
Li G; Yan QB; Wei LM
Chin Med Sci J; 2006 Sep; 21(3):175-8. PubMed ID: 17086740
[TBL] [Abstract][Full Text] [Related]
18. [Role of soluble Fas ligand in myocardial remodeling, severity and outcomes of chronic heart failure].
Teplyakov AT; Berezikova EN; Shilov SN; Grakova EV; Torim YY; Efremov AV; Popova AA; Pustovetova MG; Sabirova AY; Kopyeva KV
Ter Arkh; 2016; 88(9):10-16. PubMed ID: 27735908
[TBL] [Abstract][Full Text] [Related]
19. [Plasma chromogranin-A (CgA)--a potential marker for diagnosis, monitoring and management of prostate cancer patients].
Leibovitch I; Pinthus Y; Sella BA; Ramon J
Harefuah; 2006 Jan; 145(1):25-9, 78. PubMed ID: 16450720
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum chromogranin A precedes prostate-specific antigen elevation and predicts failure of androgen deprivation therapy in patients with advanced prostate cancer.
Chuang CK; Wu TL; Tsao KC; Liao SK
J Formos Med Assoc; 2003 Jul; 102(7):480-5. PubMed ID: 14517586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
